<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR25">
 <label>25.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Jansen</surname>
    <given-names>YJL</given-names>
   </name>
   <name>
    <surname>Rozeman</surname>
    <given-names>EA</given-names>
   </name>
   <name>
    <surname>Mason</surname>
    <given-names>R</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Discontinuation of anti-PD-1 antibody therapy in the absence of disease progression or treatment limiting toxicity: clinical outcomes in advanced melanoma</article-title>
  <source>Ann Oncol</source>
  <year>2019</year>
  <volume>30</volume>
  <issue>7</issue>
  <fpage>1154</fpage>
  <lpage>1161</lpage>
  <pub-id pub-id-type="doi">10.1093/annonc/mdz110</pub-id>
  <?supplied-pmid 30923820?>
  <pub-id pub-id-type="pmid">30923820</pub-id>
 </element-citation>
</ref>
